Haven uitbreiden Meerdere kappa opioid receptor Vrijgevigheid zo veel over het algemeen
PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age | Neuropsychopharmacology
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
κ-Opioid Receptor (KOP) | 7TM Antibodies
Opioids in cancer: The κ‑opioid receptor (Review)
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
The Role of Opioids and Their Receptors in Urological Malignancy: A Review
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
opioid receptor (English) - Medical terminology for medical students - - YouTube
κ-opioid receptor - Wikipedia
Asymmetric syntheses of (+)- and (–)-collybolide enable reevaluation of kappa-opioid receptor agonism | Organic Chemistry | ChemRxiv | Cambridge Open Engage
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Kappa opioid receptor labeled with Tb (HTRF transiently expressing cells)
Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications - ScienceDirect
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect